Bayesian Capital Management’s Cardinal Health CAH Stock Holding History

Bayesian Capital Management’s Portfolio CAH Stock Details CAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-14,300	Closed	-$1.58M	–	716
2024 Q3	$1.58M	Buy	+14,300	New	+$1.5M	0.19%	163
2020 Q4	–	Sell	-45,500	Closed	-$2.14M	–	469
2020 Q3	$2.14M	Buy	45,500 +15,000	+49%	+$770K	0.52%	38
2020 Q2	$1.59M	Sell	30,500 -3,900	-11%	-$201K	0.35%	61
2020 Q1	$1.65M	Buy	34,400 +22,900	+199%	+$1.19M	0.36%	57
2019 Q4	$582K	Buy	+11,500	New	+$594K	0.1%	278
2019 Q2	–	Sell	-22,400	Closed	-$1.08M	–	526
2019 Q1	$1.08M	Buy	+22,400	New	+$1.12M	0.21%	152
2018 Q2	–	Sell	-6,300	Closed	-$395K	–	603
2018 Q1	$395K	Buy	+6,300	New	+$432K	0.1%	325
2017 Q1	–	Sell	-23,728	Closed	-$1.71M	–	427
2016 Q4	$1.71M	Buy	+23,728	New	+$1.72M	0.42%	39
2016 Q1	–	Sell	-4,413	Closed	-$394K	–	360
2015 Q4	$394K	Buy	+4,413	New	+$375K	0.56%	53

Other funds holding CAH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Bayesian Capital Management's CAH Position: Q4 2024 in Review

Bayesian Capital Management sold out of Cardinal Health (CAH) in Q4 2024, closing a stake of 14,300 shares — an estimated $1.58M sold.

Bayesian Capital Management first reported a position in CAH in Q4 2015 and held it in 9 quarters. The position peaked at $2.14M in Q3 2020. 1,097 funds tracked by Wall St. Rank hold CAH as of Q4 2024.

Bayesian Capital Management reported no remaining Cardinal Health position as of Q4 2024 after selling out during the quarter.
Bayesian Capital Management sold 14,300 Cardinal Health shares in Q4 2024, an estimated $1.58M.
Bayesian Capital Management first reported a position in Cardinal Health in Q4 2015 and held it in 9 quarters.
Bayesian Capital Management's Cardinal Health position peaked at $2.14M in Q3 2020.
1,097 funds tracked by Wall St. Rank held Cardinal Health as of Q4 2024.

Based on Bayesian Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.